Patricia Clement, Thomas Booth, Fran Borovečki, Kyrre E Emblem, Patrícia Figueiredo, Lydiane Hirschler, Radim Jančálek, Vera C Keil, Camille Maumet, Yelda Özsunar, Cyril Pernet, Jan Petr, Joana Pinto, Marion Smits, Esther A H Warnert
Purpose: There is an annual incidence of 50,000 glioma cases in Europe. The optimal treatment strategy is highly personalised, depending on tumour type, grade, spatial localization, and the degree of tissue infiltration. In research settings, advanced magnetic resonance imaging (MRI) has shown great promise as a tool to inform personalised treatment decisions. However, the use of advanced MRI in clinical practice remains scarce due to the downstream effects of siloed glioma imaging research with limited representation of MRI specialists in established consortia; and the associated lack of available tools and expertise in clinical settings...
December 3, 2020: Journal of Medical and Biological Engineering